Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

Determining the role metformin as a treatment option for patients with hidradenitis suppurative

EF 2020-21

Résumé
Hidradenitis suppurativa (HS) is a chronic inflammatory disorder characterized by painful nodules, abscess and sinus tracts in apocrine gland bearing regions. Patients affected by HS not only experience debilitating physical symptoms including pain and recurrent infections, but also under severe psychological stress secondary to their disease. Moreover, as HS is now recognized as a systemic inflammatory disease and patients with HS are also at a higher risk for developing metabolic syndrome, diabetes and cardiovascular disease. Treatment options for HS are generally limited and focus on treating the primary skin lesions. Of all the approved treatment options for HS, metformin is the only medication that has the additional benefit of also treating the cardiovascular risk factors associated with HS. Although metformin is a recommended treatment options for HS, current studies are limited to only one case report and one case series. Given the benefit of metformin on HS and its comorbidities, it is an important medication that warrants further investigation and hence the purpose of our study is to establish the first province wide HS database, which will be used to determine the impact of metformin as a treatment option in our patient population.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
449735
Name
Saxena Anjali
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Determining the role metformin as a treatment option for patients with hidradenitis suppurative
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cardiovascular Risk Factors; Diabetes; Hidradenitis Suppurativa; Hypertension; Metformin
Abstract
Hidradenitis suppurativa (HS) is a chronic inflammatory disorder characterized by painful nodules, abscess and sinus tracts in apocrine gland bearing regions. Patients affected by HS not only experience debilitating physical symptoms including pain and recurrent infections, but also under severe psychological stress secondary to their disease. Moreover, as HS is now recognized as a systemic inflammatory disease and patients with HS are also at a higher risk for developing metabolic syndrome, diabetes and cardiovascular disease. Treatment options for HS are generally limited and focus on treating the primary skin lesions. Of all the approved treatment options for HS, metformin is the only medication that has the additional benefit of also treating the cardiovascular risk factors associated with HS. Although metformin is a recommended treatment options for HS, current studies are limited to only one case report and one case series. Given the benefit of metformin on HS and its comorbidities, it is an important medication that warrants further investigation and hence the purpose of our study is to establish the first province wide HS database, which will be used to determine the impact of metformin as a treatment option in our patient population.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Saxena, Anjali
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~